Treating recurrent affective disorders during and after pregnancy. What can be taken safely?

Drug Safety

Volumn 18, Issue 2, 1998, Pages 143-152

  Schou, Magens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AFFECTIVE NEUROSIS; BREAST FEEDING; CHILD DEVELOPMENT; DRUG SAFETY; FEMALE; HUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RECURRENT DISEASE; REVIEW; RISK;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BREAST FEEDING; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DEPRESSION, POSTPARTUM; FEMALE; FETUS; HUMANS; INFANT; INFANT, NEWBORN; MOOD DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0031939486     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199818020-00006     Document Type: Review

References (78)

1. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349-52
2. Schou M, Juel-Nielsen N, Strömeren E, et al. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17: 250-60
3. Baastrup PC, Schou M. Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967; 16: 162-72
4. Baastrup PC, Poulsen JC, Schou M, et al. Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970; II: 326-30
5. Schou M. The 'Scandinavian Register of Lithium Babies'. Acta Psychiatr Scand 1969; 207 Suppl.: 97
6. Schou M, Goldfield MD, Weinstein MR, et al. Lithium and pregnancy. I. Report form the Register of Lithium Babies. BMJ 1973; 2: 135-6
7. Weinstein MR, Goldfield MD. Pharmacology: lithium teratology. In: Gershon S, Shopsin B, editors. Lithium: its role in psychiatric research and treatment. New York: Plenum, 1973: 147-66
8. Schou M. Lithium treatment during pregnancy, delivery, and lactation: an update. J Clin Psychiatry 1990; 51: 410-3
9. Källen B, Tandberg A. Lithium and pregnancy: a cohort study on manic-depressive women. Acta Psychiatr Scand 1983; 68: 134-9
10. Cunniff CM, Sahn DJ, Reed KL, et al. Pregnancy outcome in women treated with lithium [abstract]. Teratology 1989; 39: 447
11. Jacobson SJ, Jones K, Johnson K, et al. Prospective multicentre study of pregnancy outcome alter lithium exposure during first trimester. Lancet 1992; 339: 530-3
12. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146-50
13. Zalzstein E, Koren G, Einarson T, et al. A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 1990; 65: 817-8
14. Edmonds LD, Oakley GP. Ebstein's anomaly and maternal lithium exposure during pregnancy. Teratology 1990; 41: 551-2
15. Sipek A. Lithium and Ebstein's anomaly. Cor Vasa 1989; 31: 149-56
16. Källen SJB. Lithium therapy and congenital malformations. In: Schrauzer GN, Klippel KF, editors. Lithium in biology and medicine: new applications and developments. Weinheim: New York, 1991: 121-30
17. Thomsen K, Schou M. Renal lithium excretion in man. Am J Physiol 1968; 215: 823-7
18. Schou M, Amdisen A, Steenstrup OR. Lithium and pregnancy. II: hazards to women given lithium during pregnancy and delivery. BMJ 1973; 2: 137-8
19. Wilbanks GD, Bressler B, Peete CH, et al. Toxic effects of lithium carbonate in a mother and newborn infant. JAMA 1970; 213: 865-7
20. Vacaflor L, Lehmann HE, Ban TA. Side effects and teratogenicity of lithium carbonate treatment. J Clin Pharmacol 1970; 10: 387-9
21. Nishiwaki T, Tanaka K, Sekiya S. Acute lithium intoxication in pregnancy. Int J Gynecol Obstet 1996; 52: 191-2
22. Tunnesen WW, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatrics 1972; 81: 804-7
23. Stothers K, Wilson DW, Royston N. Lithium toxicity in the newborn. BMJ 1973; 3: 233-4
24. Stevens D, Burman D, Midwinter A. Transplacental lithium poisoning. Lancet 1974; II: 595
25. Nars P, Girard J. Lithium carbonate intake during pregnancy leading to large goiter in a premature infant. Am J Dis Child 1977; 131: 924-5
26. Mizrahi EM, Hobbs JF, Goldsmith DI. Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatrics 1979; 94: 493-5
27. Arnon RG, Marin-Garcia J, Peeden JN. Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant. Am J Dis Childhood 1981; 135: 941-3
28. Filtenborg JA. Persistent pulmonary hypertension after lithium intoxication in the newborn. Eur J Pediatr 1982; 138: 321-3
29. Morrell P, Sutherland GR, Buamah PK, et al. Lithium toxicity in a neonate. Arch Dis Child 1983; 58: 539-41
30. Wilson N, Forfar JC, Godman MJ. Atrial flutter in the newborn resulting from maternal lithium ingestion. Arch Dis Child 1983; 58: 538-49
31. Krause S, Ebbesen F, Lange AP. Polyhydramnios with maternal lithium treatment. Obstet Gynecol 1990; 75: 504-6
32. Ang MS, Thorp JA, Parisi VM. Maternal lithium therapy and polyhydramnios. Obstet Gynecol 1990; 76: 517-9
33. Kastrup M, Lier L, Rafaelsen OJ. Psychiatric illness in relation to pregnancy and childbirth. I. Methodological considerations. Nord Psykiatr Tidsskr 1989; 43: 531-4
34. Lier L, Kastrup M, Rafaelsen OJ. Psychiatric illness in relation to pregnancy and childbirth. II. Diagnostic profiles, psychosocial ami perinatal aspects. Nord Psykiatr Tidsskr 1989; 43: 535-42
35. Austin MV. Puerperal affective psychosis: is there a case for lithium prophylaxis? Br J Psychiatry 1992; 161: 692-4
36. Cohen LS, Sichel DA, Robertson LM, et al. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995; 152: 1641-5
37. Schou M, Amdisen A. Lithium and pregnancy. III: lithium ingestion by children breast-fed by women on lithium treatment. BMJ 1973; 2: 138
38. Schou M. Lithium treatment of manic-depressive illness: a practical guide. 4th rev ed. Basel: Karger, 1989
39. Skausig OB, Schou M. Diegivning under lithiumbehandling. Ugeskr Læg 1977; 139: 400-1
40. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153: 1132-7
41. Schou M. Lithium treatment of manic-depressive illness: a practical guide. 5th rev ed. Basel: Karger, 1993
42. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 1976; 54: 193-7
43. Wehr TA, Goodwill FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555-9
44. Akiskal HS, Mallya G. Criteria for the 'soft' bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23: 68-73
45. Allschuler LL, Cohen L, Szuba MP, et al. Pharmacological management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153: 592-606
46. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269: 2246-8
47. McElhatton PR, Garbis HM, Elefant E, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. Reprod Toxicol 1996; 10: 285-94
48. Chambers CD, Johnson KA, Dick LM, et al. Birth outcome in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010-5
49. Robert E. Treating depression in pregnancy. N Engl J Med 1996; 335: 1056-8
50. Cohen LS, Rosenbaum JF. Birth outcome in pregnant women taking fluoxetine [letter]. N Engl J Med 1997; 336: 872
51. Goldstein DJ, Sundell KL, Corbin LA. Birth outcomes in pregnant women taking fluoxetine [letter]. N Engl J Med 1997; 336: 872-3
52. Jones KL, Johnson KA, Chambers CD. Birth outcomes in pregnant women taking fluoxetine [letter]. N Engl J Med 1997; 336: 873
53. Webster PAC. Withdrawal symptoms in neonates associated with maternal antidepressants therapy [letter]. Lancet 1973; II: 3189
54. Eggermont E. Withdrawal symptoms in neonates associated with maternal imipramine therapy [letter]. Lancet 1973: II: 680
55. Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. BMJ 1982; 284: 1837-8
56. Spencer MJ. Fluoxetine hydrochloride (Prozac) toxicity in the neonate. Pediatrics 1993; 92: 721-2
57. Baum AL, Misri S. Selective serotonin-reuptake inhibitors in pregnancy and lactation. Harvard Rev Psychiatry 1996; 4: 117-25
58. Lidén K, Ellström KG. Obervandum om antidepressiva under graviditet: Även läga doser kan paverka barnet. Läkartidn 1997; 94: 2086-91
59. Wisner KL, Wheeler SB. Prevention of recurrent postpartum major depression. Hosp Commun Psychiatry 1994; 45: 1191-6
60. Altschuler LL, Burt VK, McMullen M, et al. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995; 56: 243-5
61. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996; 36: 42-7
62. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding Am J Psychiatry 1996; 153: 1132-7
63. Yoshida K, Smith B, Craggs M, et al. Investigation of pharmacokinetics and of possible adverse effects in intants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 1997; 43: 225-37
64. Mammen OK, Perel JM, Rudolph G, et al. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 1997; 58: 100-3
65. Jensen PN, Olesen OV, Bertelsen A, et al. Citalopram and desmethylcitalopram in breast milk and in serum of mother and infant. Ther Drug Monit 1997; 18: 236-9
66. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336: 258-62
67. Jones KL, Lacro RV, Johnson KA, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320: 1661-6
68. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324: 674-7
69. Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996; 75: 517-20
70. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects [letter]. Lancet 1982; II: 937
71. Bjerkedal T, Czeizel A, Goujard J, et al. Valproic acid and spina bifida [letter]. Lancet 1982: II: 1096
72. Lindhout D, Meinardi H. Spina bifida and in-utero exposure to valproic acid. Lancet 1984; II: 396
73. DiLiberti JH, Farndon PA, Dennis NR, et al. The fetal valproate syndrome. Am Med J Genet 1984; 19: 473-81
74. Ardinger HH, Alkin JF, Blackston D, et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988; 29: 171-85
75. Thisted E, Ebbesen F. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child 1993; 69: 288-91
76. Battino D, Binelli S, Caccamo ML, et al. Malformations in offspring ot 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85: 204-7
77. Niebyl JR, Blake DA, Freeman JM, et al. Carbamazepine levels in pregnancy and lactation. Obstet Gynecol 1979; 53: 139-40
78. Abrams R. Electroconvulsive therapy. 2nd ed. New York: Oxford University Press, 1992: 103-4